✦ LIBER ✦

55 - A phase III randomised study of carboplatin and amifostine (A) vs carboplatin and G-CSF in patients with inoperable non small cell lung cancer (NSCLC)

✍ Scribed by H. Anderson; V. Mercer; L. Russell; N. Habboubi; N. Thatcher

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase III randomized study of carbopla

✍ Belani, C.P; Ansari, R.H; Atkins, J.N; Hon, J.K; Modiano, M.R; Budd, T.G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 104 KB

O-094 Paclitaxel and gemcitabine vs carb

✍ Kosmidis, P.; Kalofonos, C.; Syrigos, K.; Skarlos, D.; Fountzilas, G.; Nicolaide 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Phase II study with mitomycin, ifosfamid

✍ A. von Rohr; H. Anderson; R. McIntosh; N. Thatcher 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 348 KB

58 GLOB 2: a randomised phase III study

✍ E.H. Tan; R. Abratt; M. Krzakowski; U. Gatzemeier; K. Mattson; M. Wernil; P. Rei 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 161 KB

A phase I pharmacokinetic study of bexar

✍ Jordi Rodon; Charlotte D. Jacobs; Quincy Chu; Eric K. Rowinsky; Arturo Lopez-Ana 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 277 KB

Paclitaxel (T) and carboplatin (C): A ph

✍ Fírvida, J.L; Amenedo, M; Salgado, M; Gonzalez-Quintas, A; Garcia Mata, J; Losad 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB